These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. Finlay GA, Malhowski AJ, Liu Y, Fanburg BL, Kwiatkowski DJ, Toksoz D. Cancer Res; 2007 Oct 15; 67(20):9878-86. PubMed ID: 17942919 [Abstract] [Full Text] [Related]
6. Measurements of TSC2 GAP activity toward Rheb. Li Y, Inoki K, Vikis H, Guan KL. Methods Enzymol; 2006 Oct 15; 407():46-54. PubMed ID: 16757313 [Abstract] [Full Text] [Related]
7. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. El-Hashemite N, Walker V, Zhang H, Kwiatkowski DJ. Cancer Res; 2003 Sep 01; 63(17):5173-7. PubMed ID: 14500340 [Abstract] [Full Text] [Related]
8. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin. Finlay GA, Thannickal VJ, Fanburg BL, Kwiatkowski DJ. Cancer Res; 2005 Dec 01; 65(23):10881-90. PubMed ID: 16322235 [Abstract] [Full Text] [Related]
9. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Jones KA, Jiang X, Yamamoto Y, Yeung RS. Exp Cell Res; 2004 May 01; 295(2):512-24. PubMed ID: 15093748 [Abstract] [Full Text] [Related]
10. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Cancer Res; 2007 Aug 01; 67(15):7106-12. PubMed ID: 17671177 [Abstract] [Full Text] [Related]
13. Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. Nellist M, Burgers PC, van den Ouweland AM, Halley DJ, Luider TM. Biochem Biophys Res Commun; 2005 Aug 05; 333(3):818-26. PubMed ID: 15963462 [Abstract] [Full Text] [Related]
14. TOR signaling. Harris TE, Lawrence JC. Sci STKE; 2003 Dec 09; 2003(212):re15. PubMed ID: 14668532 [Abstract] [Full Text] [Related]
15. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. Marsh J, Mukherjee P, Seyfried TN. Clin Cancer Res; 2008 Dec 01; 14(23):7751-62. PubMed ID: 19047102 [Abstract] [Full Text] [Related]
17. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Avruch J, Hara K, Lin Y, Liu M, Long X, Ortiz-Vega S, Yonezawa K. Oncogene; 2006 Oct 16; 25(48):6361-72. PubMed ID: 17041622 [Abstract] [Full Text] [Related]
18. Caveolin regulates microtubule polymerization in the vascular smooth muscle cells. Kawabe J, Okumura S, Nathanson MA, Hasebe N, Ishikawa Y. Biochem Biophys Res Commun; 2006 Mar 31; 342(1):164-9. PubMed ID: 16480946 [Abstract] [Full Text] [Related]
20. Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability. Peth A, Boettcher JP, Dubiel W. J Mol Biol; 2007 Apr 27; 368(2):550-63. PubMed ID: 17350042 [Abstract] [Full Text] [Related] Page: [Next] [New Search]